The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial

被引：0
|
作者：
M Gnant
G Pfeiler
H Stöger
B Mlineritsch
F Fitzal
M Balic
W Kwasny
M Seifert
M Stierer
P Dubsky
R Greil
G Steger
H Samonigg
C Fesl
R Jakesz
机构：
[1] Comprehensive Cancer Center,Department of Surgery
[2] Medical University of Vienna,Division of Gynecology and Gynecological Oncology, Department of OB/GYN
[3] Comprehensive Cancer Center,Department of Medical Oncology
[4] Medical University of Vienna,IIIrd Medical Department with Hematology and Medical Oncology
[5] Medical University of Graz,Department of Surgery
[6] Hemostaeology,Department of Surgery
[7] Infectious Disease and Rheumatology,Division of Oncology, Department of Internal Medicine I
[8] Oncology Center,Department of Statistics
[9] Paracelus Medical University Hospital Salzburg,undefined
[10] Wiener Neustadt Hospital,undefined
[11] Hanusch Medical Center,undefined
[12] Medical University of Vienna,undefined
[13] Austrian Breast and Colorectal Cancer Study Group,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
breast cancer; endocrine therapy; BMI; aromatase inhibitor; extended therapy; obesity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：589 / 596
页数：7
相关论文
共 50 条
  • [1] The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
    Gnant, M.
    Pfeiler, G.
    Stoeger, H.
    Mlineritsch, B.
    Fitzal, F.
    Balic, M.
    Kwasny, W.
    Seifert, M.
    Stierer, M.
    Dubsky, P.
    Greil, R.
    Steger, G.
    Samonigg, H.
    Fesl, C.
    Jakesz, R.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 109 (03) : 589 - 596
  • [2] Impact of Body Mass Index (BMI) on the Efficacy of Endocrine Therapy in Postmenopausal Breast Cancer Patients - An Analysis of the ABCSG 6 and 6a Trial
    Pfeiler, G.
    Stoeger, H.
    Singer, C.
    Seifert, M.
    Jakesz, R.
    Dubsky, P.
    Samonigg, H.
    Greil, R.
    Menzel, C.
    Heck, D.
    Gnant, M.
    [J]. CANCER RESEARCH, 2010, 70
  • [3] Extended adjuvant treatment with anastrozole: Results from the Austrian breast and colorectal cancer study group trial 6a (ABCSG-6a).
    Jakesz, R
    Samonigg, H
    Greil, R
    Gnant, M
    Schmid, M
    Kwasny, W
    Kubista, E
    Mlineritsch, B
    Tausch, C
    Stierer, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 10S - 10S
  • [4] Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial
    Pfeiler, Georg
    Koenigsberg, Robert
    Fesl, Christian
    Mlineritsch, Brigitte
    Stoeger, Herbert
    Singer, Christian F.
    Poestlberger, Sabine
    Steger, Guenther G.
    Seifert, Michael
    Dubsky, Peter
    Taucher, Susanne
    Samonigg, Hellmut
    Bjelic-Radisic, Vesna
    Greil, Richard
    Marth, Christian
    Gnant, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) : 2653 - 2659
  • [5] Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: Emerging data
    Buzdar, AU
    Cuzick, J
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (03) : 1037S - 1048S
  • [6] Impact of body mass index (BMI) on endocrine therapy in premenopausal breast cancer patients: An analysis of the ABCSG-12 trial.
    Pfeiler, G.
    Koenigsberg, R.
    Singer, C. F.
    Seifert, M.
    Dubsky, P. C.
    Samonigg, H.
    Bjelic-Radisic, V.
    Greil, R.
    Marth, C.
    Gnant, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial
    Pfeiler, G.
    Koenigsberg, R.
    Mlineritsch, B.
    Stoger, H.
    Singer, C. F.
    Poestlberger, S.
    Steger, G.
    Seifert, M.
    Dubsky, P. C.
    Jakesz, R.
    Samonigg, H.
    Bjelic-Radisic, V.
    Greil, R.
    Marth, C.
    Fesl, C.
    Gnant, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] The Impact of Body Mass Index (BMI) on the Efficacy of Adjuvant Endocrine Therapy in Postmenopausal Hormone Sensitive Breast Cancer (BC) Patients; Exploratory Analysis from the TEAM Study
    Seynaeve, C.
    Hille, E.
    Hasenburg, A.
    Rea, D.
    Markopoulos, C.
    Hozumi, Y.
    Putter, H.
    Nortier, H.
    van Nes, J.
    Dirix, L.
    van de Velde, C.
    [J]. CANCER RESEARCH, 2010, 70
  • [9] Impact of body mass index (BMI) on the efficacy of zoledronic acid in premenopausal patients with hormone receptor positive breast cancer: An analysis of the ABCSG-12 trial.
    Pfeiler, Georg
    Konigsberg, Robert
    Fesl, Christian
    Mlineritsch, Brigitte
    Stoger, Herbert
    Singer, Christian F.
    Poestlberger, Sabine
    Steger, Guenther G.
    Seifert, Michael
    Dubsky, Peter Christian
    Jakesz, Raimund
    Samonigg, Hellmut
    Bjelic-Radisic, Vesna
    Greil, Richard
    Marth, Christian
    Gnant, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [10] ABCSG-16/SALSA: Prospective, open, randomised, multicentre phase III study to assess extended adjuvant treatment with 2 or 5 years' anastrozole in postmenopausal women with endocrine-responsive early breast cancer after 5 years of initial adjuvant endocrine therapy
    Gnant, M.
    Mlineritsch, B.
    Dubsky, P.
    Menzel, C.
    Schippinger, W.
    Manfreda, D.
    Poestlberger, S.
    Thaler, J.
    Stierer, M.
    Kubista, E.
    Haslbauer, F.
    Melbinger, E.
    Luschin-Ebengreuth, G.
    Sevelda, P.
    Marth, V.
    Trapl, H.
    Steger, G.
    Tausch, C.
    Fitzal, F.
    Greil, R.
    Jakesz, R.
    [J]. BREAST, 2009, 18 : S53 - S53
12345